Carregant...
28-Year Survival following Several Metastasectomies, Going through 8th Line Systemic Therapy in a Case of mRCC
Metastatic renal cell carcinoma (mRCC) has been one of the most treatment-resistant cancers because of its unpredictable clinical course, resistance to chemo- and radiotherapy, and the limited response to immunotherapy and targeted agents. We present a case of long-term survival, that is, 28 years,...
Guardat en:
| Publicat a: | Case Rep Urol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Hindawi Publishing Corporation
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4355604/ https://ncbi.nlm.nih.gov/pubmed/25810943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/523258 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|